As ETEC infections are non-invasive gastrointestinal infections, protection efficacy may depend on local mucosal immunity with anti-fimbria-specific secretory IgA in the local environment of the small intestine [15]. The gene discussed is CD79A; the disease is digestive system infectious disorder.